Needham & Company LLC Reiterates Buy Rating for Privia Health Group (NASDAQ:PRVA)

Needham & Company LLC reissued their buy rating on shares of Privia Health Group (NASDAQ:PRVA - Free Report) in a research report sent to investors on Friday,Benzinga reports. Needham & Company LLC currently has a $30.00 price objective on the stock.

A number of other research firms have also recently weighed in on PRVA. JMP Securities set a $29.00 price target on Privia Health Group in a research note on Friday, February 28th. Stephens reiterated an "overweight" rating and issued a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd. Canaccord Genuity Group raised their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research note on Friday, February 28th. JPMorgan Chase & Co. upped their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company an "overweight" rating in a research note on Friday, November 29th. Finally, Piper Sandler raised their price objective on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research report on Friday, February 28th. One equities research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $26.67.

Remove Ads

Privia Health Group Price Performance

NASDAQ PRVA traded up $0.31 during trading on Friday, reaching $23.65. 135,586 shares of the company's stock were exchanged, compared to its average volume of 752,567. The business has a 50 day moving average price of $23.65 and a 200-day moving average price of $21.05. The stock has a market capitalization of $2.85 billion, a P/E ratio of 236.52, a PEG ratio of 3.47 and a beta of 0.85. Privia Health Group has a fifty-two week low of $15.92 and a fifty-two week high of $26.04.

Hedge Funds Weigh In On Privia Health Group

Several hedge funds and other institutional investors have recently made changes to their positions in PRVA. FMR LLC boosted its position in shares of Privia Health Group by 1.5% during the 3rd quarter. FMR LLC now owns 18,169,043 shares of the company's stock worth $330,858,000 after acquiring an additional 271,645 shares in the last quarter. Durable Capital Partners LP boosted its holdings in shares of Privia Health Group by 3.4% in the 4th quarter. Durable Capital Partners LP now owns 11,487,843 shares of the company's stock valued at $224,587,000 after purchasing an additional 378,255 shares in the last quarter. Riverbridge Partners LLC increased its stake in shares of Privia Health Group by 19.7% in the 4th quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company's stock valued at $113,868,000 after purchasing an additional 958,418 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Privia Health Group by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company's stock valued at $43,986,000 after purchasing an additional 23,178 shares during the last quarter. Finally, Nuveen Asset Management LLC raised its holdings in shares of Privia Health Group by 19.8% during the 4th quarter. Nuveen Asset Management LLC now owns 1,488,979 shares of the company's stock worth $29,110,000 after buying an additional 246,393 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.